Dec 10, 2024 8:00am EST Ensysce Biosciences Announces Commercial Supplier for Breakthrough Overdose Protection Drug Product
Dec 4, 2024 8:00am EST Ensysce Biosciences Announces Strategic Partnership for the Development and Commercial Launch of PF614 and PF614-MPAR
December 20, 2023 Navigating the Future of Pain Management: Ensysce Biosciences’ Innovative Approach
June 14, 2023 Revolutionizing Pain Relief: The Next Generation of Opioids | Interview with Ensysce Biosciences CEO